Tom R. Jones

Discovery of a Potent and Selective Prostaglandin D₂ Receptor Antagonist, [(3<i>R</i>)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[<i>b</i>]indol-3-yl]-acetic Acid (MK-0524)

Claudio F. Sturino, Gary P. O’Neill, Nicolas Lachance et al. · Journal of Medicinal Chemistry · 2007 · 170 citations · Full text

Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.

Tom R. Jones, L. Charette, María L. García et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 151 citations

Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(<i>t</i>-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor

Christine Brideau, Christine Chan, S. Charleson et al. · Canadian Journal of Physiology and Pharmacology · 1992 · 112 citations

Lipid Peroxidation, Whole Blood, Experimental Pharmacology +17

Dioxabicyclooctanyl Naphthalenenitriles as Nonredox 5-Lipoxygenase Inhibitors:  Structure−Activity Relationship Study Directed toward the Improvement of Metabolic Stability

Daniel Delorme, Yves Ducharme, Christine Brideau et al. · Journal of Medicinal Chemistry · 1996 · 62 citations · Full text

Discovery of L-791,943: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor

Daniel Guay, Pierre Hamel, Marc Blouin et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 56 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Drug Target +10